Anti-CEA [161 (NCRC16)]
Invented by Prof Lindy Durrant at University of Nottingham
- Datasheet
- Reviews (0)
Info
| Catalogue Number | 151306 |
| Applications | ELISA IP WB |
| Antigen/Gene or Protein Targets | Carcinoembryonic Antigen (CEA) |
| Reactivity | Human |
| Relevance | Carcinoembryonic antigen is a diagnostic marker for many cancers including colorectal, hepatoma, neuroendocrine, lung, neuroblastoma, breast, pancreatic, trophoblastic and ovarian cancers. |
| Host | Mouse |
| Immunogen | Colon cancer cell lines |
| Positive Control | LS174 T cells, colon carcinoma |
| Subclass | IgG1 |
| Myeloma Used | P3/NS1/1-Ag4.1 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Cancer, Cell Type or Organelle Marker |
References: 2 entries
Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485.
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
Europe PMC ID: 2481485
Add a reference
References: 2 entries
Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485.
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
Europe PMC ID: 2481485
Add a reference
References: 2 entries
Durrant et al. 1989. Br J Cancer. 60(6):855-60. PMID: 2481485.
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
Add a reference
Have you used this reagent? Share your experience by submitting a review and help your fellow scientists.
Review this reagent